Even though there are several reports indicating the trend of outsourcing clinical trails to India, trials conducted in India only represent two percent of the worldwide total according to this article in Fierce Biotech.
The research group RNCOS also expects the number to surge to 5 percent by 2012 as more companies look to conduct low-cost trials in India. According to RNCO,
"companies can cut up to 30 to 40 percent time required to complete various phases of clinical trials choosing
Take a look at RNCO’s full release here.
No comments:
Post a Comment